Factors influencing the concentration of valproic acid in patients with diagnosed epilepsy

被引：0
|
作者：
Szczygiel-Pilut, E. [1 ,2 ]
机构：
[1] John Paul 2 Hosp, Dept Neurol, Substroke Unit, Krakow, Poland
[2] John Paul 2 Hosp, Subdept Neurol Rehabil, Krakow, Poland
来源：
EPILEPSIA | 2022年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
774
引用
收藏
页码：77 / 77
页数：1
相关论文
共 50 条
  • [1] Risk factors of hyperammonemia in epilepsy patients with valproic acid therapy
    Kwack, Dong Won
    Kim, Dong Wook
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2023, 233
  • [2] Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy
    Mei, Shenghui
    Feng, Weixing
    Zhu, Leting
    Yu, Yazhen
    Yang, Weili
    Gao, Baoqin
    Wu, Xiaojuan
    Zhao, Zhigang
    Fang, Fang
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2017, 51 : 22 - 26
  • [3] Risk Factors of Hyperammonemia in Patients With Epilepsy Under Valproic Acid Therapy
    Tseng, Yu-Lung
    Huang, Chi-Ren
    Lin, Chih-Hsiang
    Lu, Yan-Ting
    Lu, Cheng-Hsien
    Chen, Nai-Ching
    Chang, Chiung-Chih
    Chang, Wen-Neng
    Chuang, Yao-Chung
    MEDICINE, 2014, 93 (11) : e66
  • [4] Factors Influencing Plasma Concentrations of Valproic Acid in Pediatric Patients With Epilepsy and the Clinical Significance of CYP2C9 Genotypes in Personalized Valproic Acid Therapy
    Ma, Bingsuo
    Yang, Kun
    Li, Xinping
    Su, Ning
    Yu, Ting
    Zou, Yan
    Xu, Xingmeng
    Wang, Fei
    Cheng, Jingdong
    Yan, Zijun
    Chen, Tong
    Zhang, Liangming
    THERAPEUTIC DRUG MONITORING, 2024, 46 (04) : 503 - 511
  • [5] Risk factors for hyperammonemia associated with valproic acid therapy in adult epilepsy patients
    Yamamoto, Yoshiaki
    Takahashi, Yukitoshi
    Suzuki, Eri
    Mishima, Nobuyuki
    Inoue, Kazuyuki
    Itoh, Kunihiko
    Kagawa, Yoshiyuki
    Inoue, Yushi
    EPILEPSY RESEARCH, 2012, 101 (03) : 202 - 209
  • [6] Effect of valproic acid on depression in epilepsy patients
    Kharchuk, S
    Shcheglova, Y
    EPILEPSIA, 2005, 46 : 266 - 266
  • [7] VALPROIC ACID IN EPILEPSY
    LIVINGSTON, S
    PAULI, LL
    PRUCE, I
    KRAMER, II
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 241 (18): : 1892 - 1892
  • [8] VALPROIC ACID IN EPILEPSY
    BERMAN, W
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 243 (05): : 431 - 431
  • [9] Risk Factors for Valproic Acid-induced Hyperammonaemia in Chinese Paediatric Patients with Epilepsy
    Zhu, Xu
    Li, Xinlin
    Zhang, Ti
    Zhao, Limei
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 (05) : 628 - 634
  • [10] Dynamics of hydroxyoctadecadienoic acid in epilepsy patients treated with valproic acid
    Azumagawa, Kohji
    Mino, Makoto
    Ishida, Noriko
    Shichiri, Mototada
    Shigeri, Yasushi
    Yoshida, Yasukazu
    Tamai, Hiroshi
    PEDIATRICS INTERNATIONAL, 2016, 58 (01) : 45 - 48
12345